HUL Unveils WINI Strategy, Raises EBITDA Guidance to 22‑24%

Key Financial Takeaways

  • HUL shifts from its previous WIMI model to a WINI strategy focused on new India markets.
  • The company has increased its upper EBITDA margin band to 22‑24% (previously 23.5%).
  • Growth is expected to come 40% from consumption/premiumisation, 40% from a larger user base, and 20% from innovations.
  • Analysts project a 9% sales CAGR and 8.8% PAT CAGR for FY26‑28.
  • HUL trades at 38.6x FY28 EPS, with a 2%+ dividend yield and a target price of Rs 2,320.

💡 Why It Matters

HUL’s strategic pivot to WINI reflects a broader shift in India’s FMCG sector toward premiumisation and market expansion. By raising its EBITDA guidance and outlining clear growth drivers, the company provides investors with a more transparent roadmap for value creation. The updated valuation metrics also offer a benchmark for assessing HUL’s future performance relative to peers.

HUL’s New Growth Blueprint

Hindustan Unilever Limited (HUL) has outlined a fresh growth agenda under the acronym WINI – *Winning in New India*. The strategy departs from the earlier WIMI (Winning in Many India) model and places a premium on three levers:

1. **Premiumisation** – raising the average selling price through higher‑value products. 2. **Higher usage** – encouraging more frequent consumption of existing brands. 3. **Market making** – entering high‑growth categories and expanding distribution.

Management highlighted that these initiatives will be financed by savings generated from sourcing efficiencies, media effectiveness and cost‑control measures. The company also plans to increase capital expenditure on new product development and market expansion.

Financial Outlook and Valuation

In its latest guidance, HUL has raised the upper band of its EBITDA margin forecast to **22‑24%**, a shift from the previously quoted 23.5% band. The company expects the margin lift to be driven by the volume‑led growth model and the cost‑saving measures mentioned above.

Analysts estimate a **9% compound annual growth rate (CAGR)** in sales and an **8.8% CAGR** in profit after tax (PAT) for the period FY26‑28. At a valuation of **38.6 times FY28 earnings**, HUL sits at the lowest multiple in a decade, yet the 2%+ dividend yield is viewed as a favourable risk‑reward balance.

Competitive Landscape and Risks

While the Home Care and Toilet Soaps segments remain highly competitive, HUL’s foray into Beauty & Wellbeing and Nutrition is expected to offset pricing pressure. However, analysts caution that higher inflation and El Nino‑induced supply disruptions could dampen short‑term growth and margin performance.

Analyst Consensus

The research report recommends an **Accumulate** rating with a target price of **Rs 2,320** (45× FY28 earnings). The consensus view is that the company’s strategic shift and margin outlook provide a solid foundation for long‑term value creation.

Bottom Line

HUL’s WINI strategy signals a decisive move toward capturing new growth opportunities in India’s evolving consumer landscape. By aligning premiumisation, usage, and market expansion, the company aims to sustain volume‑led revenue growth while improving profitability.

What to Watch

- **Quarterly earnings** for evidence of the margin lift and volume growth. - **Performance of Beauty & Wellbeing and Nutrition** categories, which are key to offsetting competitive pressure. - **Inflationary and supply‑chain developments**, especially those linked to El Nino, that could impact cost structures.

These factors will shape HUL’s trajectory in the coming fiscal years.

🏛️ Background & Context

HUL has historically relied on a WIMI model, focusing on capturing market share across existing categories. The new WINI framework represents a strategic response to intensifying competition and changing consumer preferences, particularly in the premium and health‑centric segments.

👁️ What To Watch Next

Investors should monitor HUL’s quarterly results for evidence of the projected margin improvement and volume growth, track the performance of its Beauty & Wellbeing and Nutrition lines, and stay alert to macroeconomic factors such as inflation and supply‑chain disruptions that could influence cost dynamics.

Source Attribution:
  • Moneycontrol.com